Sign in to view content

Suprachoroidal Delivery of RGX-314 for Diabetic Retinopathy Without CI-DME: Early Results From the Phase II ALTITUDE Study

Dennis M. Marcus, MD

Video
Published 2021

Related

MCO-010 Optogenetic Therapy for Severe Vision Loss in Stargardt Disease: 6-Month Outcomes From the Phase 2 STARLIGHT Trial
Allen C Ho, MD FASRS
Annual Meeting Talks
2023
Robotic Surgery as a Delivery Tool for Novel Retinal Therapies
Lyndon da Cruz, MBBS, BA, MA, FRCOphth, PhD, FRACO
Updates from the Field
2019
Intermittent to Continuous Therapy for Diabetic Macular Edema leads to Reduction in Treatment Frequency and Reduced Retinal Thickness Fluctuations
Seenu M. Hariprasad, MD
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more